Strategic Expansion Rutgers Cancer Institute is expanding presence with a new Melchiorre Cancer Center in Livingston, NJ, signaling growth opportunities for OEM partnerships, equipment vendors, and service contracts focused on multi-site cancer care delivery.

Affiliation & Scale As New Jersey’s only NCI-designated comprehensive cancer center and part of Rutgers University, the institute represents a high-profile customer with substantial grant activity, potential for clinical trial collaborations, and long-term procurement of research and clinical support technologies.

Research & Innovation Active collaborations in immunotherapy, ctDNA MRD testing, and risk prediction models indicate opportunities for diagnostic platforms, bioinformatics, data analytics, and lab automation solutions aligned with cutting-edge oncology research.

Clinical Excellence Engagement in ASCO events and recognition by V Foundation underscores a focus on advanced patient care, suggesting needs for patient management systems, imaging, radiology workflow tools, and AI-driven clinical decision support.

Strategic Partnerships Partnerships with RWJBarnabas Health and industry players (e.g., Haystack Oncology) reflect a collaborative ecosystem; identify co-sell or channel opportunities for oncology informatics, MRD testing, and centralized supply/services across a multi-hospital network.